1,476
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Inflammatory factor expression in HaCaT cells and melanin synthesis in melanocytes: Effects of Ganoderma lucidum fermentation broth containing Chinese medicine

, , , , , , & show all
Pages 1604-1621 | Received 11 Feb 2022, Accepted 25 Jun 2022, Published online: 05 Jul 2022

References

  • Kunchana, K.; Jarisarapurin, W.; Chularojmontri, L.; Wattanapitayakul, S. K. Potential use of amla (Phyllanthus Emblica L.) Fruit extract to protect skin keratinocytes from inflammation and apoptosis after UVB irradiation. Antioxidants. 2021, 10, 703. DOI: 10.3390/antiox10050703.
  • Wang, L.; Oh, J. Y.; Jayawardena, T. U.; Jeon, Y. J.; Ryu, B. Anti-inflammatory and anti-melanogenesis activities of sulfated polysaccharides isolated from Hizikia Fusiforme: Short communication. Int. J. Biol. Macromol. 2020, 142, 545–550. DOI: 10.1016/j.ijbiomac.2019.09.128.
  • Fu, C.; Chen, J.; Lu, J.; Yi, L.; Tong, X.; Kang, L.; Pei, S.; Ouyang, Y.; Jiang, L.; Ding, Y.; et al. Roles of inflammation factors in melanogenesis (Review). Mol. Med. Rep. 2020, 21, 1421–1430. DOI: 10.3892/mmr.2020.10950.
  • Chaturvedi, V. K.; Agarwal, S.; Gupta, K. K.; Ramteke, P. W.; Singh, M. P. Medicinal mushroom: boon for therapeutic applications. 3 Biotech. 2018, 8, 334. DOI: 10.1007/s13205-018-1358-0.
  • Boh, B.; Berovic, M.; Zhang, J.; Zhi-Bin, L. Ganoderma Lucidum and its pharmaceutically active compounds. Biotechnol. Annu. Rev. 2007, 13, 265–301. DOI: 10.1016/s1387-2656(07)13010-6.
  • Wu, Y. L.; Han, F.; Luan, S. S.; Ai, R.; Zhang, P.; Li, H.; Chen, L. X. Triterpenoids from Ganoderma Lucidum and their potential anti-inflammatory effects. J. Agric. Food Chem. 2019, 67, 5147–5158. DOI: 10.1021/acs.jafc.9b01195.
  • Lu, S. Y.; Peng, X. R.; Dong, J. R.; Yan, H.; Kong, Q. H.; Shi, Q. Q.; Li, D. S.; Zhou, L.; Li, Z. R.; Qiu, M. H. Aromatic constituents from Ganoderma Lucidum and their neuroprotective and anti-inflammatory activities. Fitoterapia. 2019, 134, 58–64. DOI: 10.1016/j.fitote.2019.01.013.
  • Abate, M.; Pepe, G.; Randino, R.; Pisanti, S.; Basilicata, M. G.; Covelli, V.; Bifulco, M.; Cabri, W.; D’Ursi, A. M.; Campiglia, P.; et al. Ganoderma Lucidum ethanol extracts enhance re-epithelialization and prevent keratinocytes from free-radical Injury. Pharmaceuticals. 2020, 13, 224. DOI: 10.3390/ph13090224.
  • Cuong, V. T.; Chen, W.; Shi, J.; Zhang, M.; Yang, H.; Wang, N.; Yang, S.; Li, J.; Yang, P.; Fei, J. The anti-oxidation and anti-aging effects of Ganoderma Lucidum in Caenorhabditis Elegans. Exp. Gerontol. 2019, 117, 99–105. DOI: 10.1016/j.exger.2018.11.016.
  • Wang, J.; Cao, B.; Zhao, H.; Feng, J. Emerging roles of Ganoderma Lucidum in anti-aging. Aging Dis. 2017, 8, 691–707. DOI: 10.14336/ad.2017.0410.
  • Jiao, C.; Xie, Y.; Yun, H.; Liang, H.; He, C.; Jiang, A.; Wu, Q.; Yang, B. B. The effect of Ganoderma Lucidum spore oil in early skin wound healing: interactions of skin microbiota and inflammation. Aging. 2020, 12, 14125–14140. DOI: 10.18632/aging.103412.
  • Hu, S.; Huang, J.; Pei, S.; Ouyang, Y.; Ding, Y.; Jiang, L.; Lu, J.; Kang, L.; Huang, L.; Xiang, H.; et al. Ganoderma Lucidum polysaccharide inhibits UVB-induced melanogenesis by antagonizing cAMP/PKA and ROS/MAPK signaling pathways. J. Cell. Physiol. 2019, 234, 7330–7340. DOI: 10.1002/jcp.27492.
  • Jiang, L.; Huang, J.; Lu, J.; Hu, S.; Pei, S.; Ouyang, Y.; Ding, Y.; Hu, Y.; Kang, L.; Huang, L.; et al. Ganoderma Lucidum polysaccharide reduces melanogenesis by inhibiting the paracrine effects of keratinocytes and fibroblasts via IL-6/STAT3/FGF2 pathway. J. Cell. Physiol. 2019, 234, 22799–22808. DOI: 10.1002/jcp.28844.
  • Yin, Z.; Yang, B.; Ren, H. Preventive and therapeutic effect of Ganoderma (Lingzhi) on skin diseases and care. Adv. Exp. Med. Biol. 2019, 1182, 311–321. DOI: 10.1007/978-981-32-9421-9_14.
  • Ahmad, R.; Riaz, M.; Khan, A.; Aljamea, A.; Algheryafi, M.; Sewaket, D.; Alqathama, A. Ganoderma Lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties. Phytother Res. 2021, 35, 6030–6062. DOI: 10.1002/ptr.7215.
  • Feng, J.; Feng, N.; Tang, Q.; Liu, Y.; Tang, C.; Zhou, S.; Wang, J.; Tan, Y.; Zhang, J.; Lin, C. C. Development and optimization of the triterpenoid and sterol production process with lingzhi or reishi medicinal mushroom, Ganoderma Lucidum Strain G0017 (Agaricomycetes), in liquid submerged fermentation at large scale. Int. J. Med. Mushrooms. 2021, 23, 43–53. DOI: 10.1615/IntJMedMushrooms.2021037830.
  • Lai, Y. J.; Hsu, K. D.; Huang, T. J.; Hsieh, C. W.; Chan, Y. H.; Cheng, K. C. Anti-melanogenic effect from submerged mycelial cultures of ganoderma weberianum. Mycobiology. 2019, 47, 112–119. DOI: 10.1080/12298093.2019.1568680.
  • Hsu, K. D.; Chen, H. J.; Wang, C. S.; Lum, C. C.; Wu, S. P.; Lin, S. P.; Cheng, K. C. Extract of ganoderma formosanum mycelium as a highly potent tyrosinase inhibitor. Sci. Rep. 2016, 6, 32854. DOI: 10.1038/srep32854.
  • Meng, H.; Liu, X. K.; Li, J. R.; Bao, T. Y.; Yi, F. Bibliometric analysis of the effects of ginseng on skin. J. Cosmet. Dermatol. 2022, 21, 99–107. DOI: 10.1111/jocd.14450.
  • Ye, Y.; Chou, G. X.; Mu, D. D.; Wang, H.; Chu, J. H.; Leung, A. K.; Fong, W. F.; Yu, Z. L. Screening of Chinese herbal medicines for antityrosinase activity in a cell free system and B16 cells. J. Ethnopharmacol. 2010, 129, 387–390. DOI: 10.1016/j.jep.2010.04.009.
  • Rundhaug, J. E.; Fischer, S. M. Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem. Photobiol. 2008, 84, 322–329. DOI: 10.1111/j.1751-1097.2007.00261.x.
  • Heard, C. M. An ex vivo skin model to probe modulation of local cutaneous arachidonic acid inflammation pathway. J. Biol. Methods. 2020, 7, e138. DOI: 10.14440/jbm.2020.319.
  • Xhindoli, D.; Pacor, S.; Benincasa, M.; Scocchi, M.; Gennaro, R.; Tossi, A. The human cathelicidin LL-37–A pore-forming antibacterial peptide and host-cell modulator. Biochim. Biophys. Acta. 2016, 1858, 546–566. DOI: 10.1016/j.bbamem.2015.11.003.
  • Wan, M.; Tang, X.; Rekha, R. S.; Muvva, S.; Brighenti, S.; Agerberth, B.; Haeggström, J. Z. Prostaglandin E(2) suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium Tuberculosis infection. FASEB J. 2018, 32, 2827–2840. DOI: 10.1096/fj.201701308.
  • Starner, R. J.; McClelland, L.; Abdel-Malek, Z.; Fricke, A.; Scott, G. PGE(2) Is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation. Exp Dermatol. 2010, 19, 682–684. DOI: 10.1111/j.1600-0625.2010.01074.x.
  • Kanlayavattanakul, M.; Lourith, N. Plants and natural products for the treatment of skin hyperpigmentation - a review. Planta Med. 2018, 84, 988–1006. DOI: 10.1055/a-0583-0410.
  • Fania, L.; Mazzanti, C.; Campione, E.; Candi, E.; Abeni, D.; Dellambra, E. Role of nicotinamide in genomic stability and skin cancer chemoprevention. Int. J. Mol. Sci. 2019, 20, 5946. DOI: 10.3390/ijms20235946.
  • Gillbro, J. M.; Olsson, M. J. The melanogenesis and mechanisms of skin-lightening agents–existing and new approaches. Int. J. Cosmet. Sci. 2011, 33, 210–221. DOI: 10.1111/j.1468-2494.2010.00616.x.
  • Dilokthornsakul, W.; Dhippayom, T.; Dilokthornsakul, P. The clinical effect of glutathione on skin color and other related skin conditions: a systematic review. J. Cosmet. Dermatol. 2019, 18, 728–737. DOI: 10.1111/jocd.12910.